Procurement Summary
Country: USA
Summary: Market Survey - Biohazardous & Pharmaceutical Waste Services
Deadline: 13 Oct 2025
Other Information
Notice Type: Tender
TOT Ref.No.: 126160771
Document Ref. No.: 091125BIO
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Description
The Federal Aviation Administration-Civil Aerospace Medical Institute (CAMI) is issuing these Sources Sought/Request for Information (RFI) as a means of conducting market research to identify potential sources having an interest to provide Pharmaceutical and Biomedical Hazardous Waste Disposal for CAMI on the Mike Monroney Aeronautical Center (MMAC) Services, Oklahoma City, Oklahoma.
The result of this market survey will contribute to the understanding of a competitive atmosphere and aid in the determination as to the method of procurement if/when a requirement materializes. Based on the responses and information provided by interested parties (i.e., vendor commercial pricing list; Business Type, GSA Schedule Contract numbers) this requirement may be set aside for small business (in full or in part) or procured through full and open competition. A single award is anticipated. All small business set-aside categories will be considered. Telephone inquiries will not be accepted or acknowledged, and no feedback or evaluations will be provided to companies regarding submissions.
CAMI intends to award a Five (5) year Contract Indefinite Delivery /Indefinite Quality (IDIQ) to a qualified vendor with capability and capacity to provide “Mail Back / On Call” Pharmaceutical and Biomedical Hazardous waste disposal services. The Contractor will furnish all personnel, materials, tools and equipment necessary to provide the removal, transportation and disposal of all Pharmaceutical and Biomedical Hazardous waste in compliance with all current local, state and federal regulations. Medical waste will consist of isolation waste, cultures, and stocks of infectious agents, and associated biological human blood, body fluids and blood products, pathological waste, contaminated sharps miscellaneous laboratory waste, discarded dressings, and contaminated linen or disposable line substitutes. The annual requirement outlined in the attached draft SOW but ge...
Active Contract Opportunity
Notice ID : 091125BIO
Related Notice
Department/Ind. Agency : TRANSPORTATION, DEPARTMENT OF
Sub-tier : FEDERAL AVIATION ADMINISTRATION
Office: 6973GH FRANCHISE ACQUISITION SVCS
General Information
Contract Opportunity Type: Sources Sought (Original)
Original Published Date: Sep 11, 2025 09:26 am CDT
Original Response Date: Oct 13, 2025 02:00 pm CDT
Inactive Policy: 15 days after response date
Original Inactive Date: Oct 28, 2025
Initiative: None
Classification
Original Set Aside: No Set aside used
Product Service Code: 6505 - DRUGS AND BIOLOGICALS
NAICS Code: 562119 - Other Waste Collection
Place of Performance: Oklahoma City, OK 73169 USA
Documents
Tender Notice
Pharma-and-Bioomedical-Waste-Disposal-Services-Dr.docx